Position in GELS
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$7,676
-$1,465 QoQ
Shares Held
11,457
-17.2% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 6 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GELS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,255,675,824 across 65 Drug Manufacturers - Specialty & Generic names. GELS ranks #64 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
9,668,611 | $237,944,516 | |
| 2 | ZTS |
Zoetis Inc.
|
3,188,263 | $229,108,578 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
304,692 | $165,091,266 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
1,376,480 | $152,706,691 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,667,827 | $109,460,941 | |
| 6 | ALKS |
Alkermes plc.
|
1,645,101 | $86,203,291 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,373,982 | $63,903,902 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
846,936 | $29,363,271 |
All Filings in GELS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,676 | 11,457 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $9,141 | 13,830 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $40,137 | 23,201 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,771 | 15,165 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $55,095 | 23,748 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||